Enochian Biosciences

+$0.02 (+0.46%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ENOB and other stocks, options, and ETFs commission-free!

About ENOB

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21.

CEO
Eric Jean Marie Leire, MD, MBA
Employees
10
Headquarters
Los Angeles, California
Founded
2011

ENOB Key Statistics

Market Cap
225.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
114.91K
High Today
$4.53
Low Today
$4.30
Open Price
$4.40
Volume
65.10K
52 Week High
$4.90
52 Week Low
$2.60

ENOB Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Sep 22, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure